MENU
IVA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Inventiva SA (IVA) Earnings Date & Reports

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation... Show more

A.I. Advisor
published Earnings

IVA is expected to report earnings to rise 35.77% to -40 cents per share on April 01

Inventiva SA IVA Stock Earnings Reports
Q4'25
Est.
$-0.41
Q3'25
Missed
by $0.01
Q2'25
Missed
by $1.02
Q4'24
Missed
by $1.39
Q3'24
Missed
by $0.20
The last earnings report on November 21 showed earnings per share of -30 cents, missing the estimate of -28 cents. With 172.29K shares outstanding, the current market capitalization sits at 813.98M.
View a ticker or compare two or three
IVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IVA showed earnings on November 21, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company, which engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
50 rue de Dijon
Phone
+33 380447500
Employees
123
Web
https://www.inventivapharma.com